Maralixibat Chloride Patent Expiration
Maralixibat Chloride is Used for treating cholestatic pruritus in patients with specific liver disorders. It was first introduced by Mirum Pharmaceuticals Inc
Maralixibat Chloride Patents
Given below is the list of patents protecting Maralixibat Chloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Livmarli | US12296050 | Pharmaceutical compositions comprising maralixibat and uses thereof | Oct 05, 2043 | Mirum |
| Livmarli | US11229647 | Methods for treating cholestasis | Feb 12, 2040 | Mirum |
| Livmarli | US11497745 | Methods for treating cholestasis | Feb 12, 2040 | Mirum |
| Livmarli | US11918578 | Methods for treating cholestasis | Feb 12, 2040 | Mirum |
| Livmarli | US10512657 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | Oct 26, 2032 | Mirum |
| Livmarli | US11229661 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | Oct 26, 2032 | Mirum |
| Livmarli | US11376251 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | Oct 26, 2032 | Mirum |
| Livmarli | US11260053 | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions | May 26, 2031 | Mirum |
Maralixibat Chloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List